SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
Nasdaq
Börse Nasdaq
ISIN US69404D1081
↓
  • Pacific Biosciences of California Inc
    Börse Nasdaq
    ISIN US69404D1081 WKN: A1C3EQ
    Symbol PACB
  • PACIFIC BIOSCIEN
    Börse Börse Stuttgart
    EUR
  • Pacific Biosciences of California
    Börse Nasdaq
    ISIN US69404D1081 WKN: A1C3EQ
    Symbol PACB
    USD
  • EUR
  • EUR
ISIN US69404D1081
WKN A1C3EQ
Symbol PACB
Börse Nasdaq Zeitzone: Europe/Berlin
Mitarbeiter 412

PACIFIC BIOSCIEN outperformed den DAX um +192 % vom 30.04.2012 bis 02.10.2020

Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 37,01 USD +7,74% 

28 News & Informationen zur PACIFIC BIOSCIEN Aktie

  • Here is What Hedge Funds Think About Pacific Biosciences of California, Inc. (PACB)
    insidermonkey.com

    Here is What Hedge Funds Think About Pacific Biosciences of California, Inc. (PACB)

    Is Pacific Biosciences of California, Inc. (NASDAQ:PACB) a good place to invest some of your money right now? We can gain invaluable insight to help us…

  • Pacific Biosciences and Invitae Announce Intent to Expand Collaboration
    globenewswire.com

    Pacific Biosciences and Invitae Announce Intent to Expand Collaboration

    Collaboration to develop production-scale HiFi Sequencing platformexpected to Include technology from Omniome, Inc. Combining both highly accurate long…

  • Should I Buy Littelfuse, Inc. (LFUS)?
    insidermonkey.com

    Should I Buy Littelfuse, Inc. (LFUS)?

    Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually…

  • Worldwide Long-Read Sequencing Industry to 2030 - Decreasing Cost of Sequencing is Driving Growth
    prnewswire.com

    Worldwide Long-Read Sequencing Industry to 2030 – Decreasing Cost of Sequencing is Driving Growth

    /PRNewswire/ — The “Global Long-Read Sequencing Market: Focus on Products and Services, Technology, Application, End User, Country Data (17 Countries), and…

  • Worldwide Long-Read Sequencing Industry to 2030 - Decreasing Cost of Sequencing is Driving Growth
    markets.businessinsider.com

    Worldwide Long-Read Sequencing Industry to 2030 – Decreasing Cost of Sequencing is Driving Growth

    DUBLIN, July 16, 2021 /PRNewswire/ — The 'Global Long-Read Sequencing Market: Focus on Products and Services, Technology, Application, End User, …

  • Worldwide Gene Expression Analysis Industry To 2026 - Key Players Include GE Healthcare, Oxford Gene Technology And Qiagen
    thestreet.com

    Worldwide Gene Expression Analysis Industry To 2026 – Key Players Include GE Healthcare, Oxford Gene Technology And Qiagen

    DUBLIN, July 15, 2021 /PRNewswire/ — The “Gene Expression Analysis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”

  • Hedge Funds Have Never Been This Bullish On Life Storage, Inc. (LSI)
    insidermonkey.com

    Hedge Funds Have Never Been This Bullish On Life Storage, Inc. (LSI)

    Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900…

  • Avitas Wealth Management LLC Buys Marathon Petroleum Corp, Signature Bank, Freeport-McMoRan Inc, Sells Best Buy Co Inc, Autodesk Inc, Delta...
    gurufocus.com

    Avitas Wealth Management LLC Buys Marathon Petroleum Corp, Signature Bank, Freeport-McMoRan Inc, Sells Best Buy Co Inc, Autodesk Inc, Delta Air Lines Inc

    GuruFocus Article or News written by insider and the topic is about:

  • 3 Cathie Wood Stocks You Can Buy for Less Than $50
    fool.com

  • Where Will ARK Genomic Revolution ETF Be in 5 Years?
    fool.com

  • The Worldwide Precision Medicine Industry is Expected to Reach $738.8 Billion by 2030
    markets.businessinsider.com

    The Worldwide Precision Medicine Industry is Expected to Reach $738.8 Billion by 2030

    DUBLIN, July 7, 2021 /PRNewswire/ — The 'Precision Medicine Market Research Report: By Type (Therapeutics, Diagnostics, Personalized Medical Care…

  • JetBlue Airways Corporation (JBLU) Fell Out Of Favor With Hedge Funds?
    insidermonkey.com

    JetBlue Airways Corporation (JBLU) Fell Out Of Favor With Hedge Funds?

    The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data….

  • Insights on the Long Read Sequencing Global Market to 2028 - by Technology, Product, Application, Workflow, End-user and Geography
    prnewswire.com

    Insights on the Long Read Sequencing Global Market to 2028 – by Technology, Product, Application, Workflow, End-user and Geography

    /PRNewswire/ — The “Long Read Sequencing Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Technology, Product, Application, Workflow, End User…

  • 10 Best Tech Stocks to Buy According to Japanese Billionaire Masayoshi Son
    insidermonkey.com

    10 Best Tech Stocks to Buy According to Japanese Billionaire Masayoshi Son

    In this article, we discuss the 10 best tech stocks to buy according to Japanese billionaire Masayoshi Son. If you want to skip our detailed analysis…

  • Here is What Hedge Funds Think About Angi Inc. (ANGI)
    insidermonkey.com

    Here is What Hedge Funds Think About Angi Inc. (ANGI)

    Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession…

  • Pacific Biosciences and Rady Children's Institute for Genomic Medicine Announce its First Research Collaboration for Whole Genome Sequencing
    marketscreener.com

    Pacific Biosciences and Rady Children's Institute for Genomic Medicine Announce its First Research Collaboration for Whole Genome Sequencing

    MENLO PARK, Calif., June 23, 2021 — Pacific Biosciences of California, Inc. , a leading provider of high-quality, long-read sequencing platforms, and Rady Children’s Institute for… | June 23, 2021

  • Pacific Biosciences And Rady Children's Institute For Genomic Medicine Announce Its First Research Collaboration For Whole Genome Sequencing
    thestreet.com

    Pacific Biosciences And Rady Children's Institute For Genomic Medicine Announce Its First Research Collaboration For Whole Genome Sequencing

    MENLO PARK, Calif., June 23, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB)(“Pacific Biosciences” or “PacBio”), a leading

  • Video
    Investflow

  • Video
    Investflow

  • Why Invitae Stock Flew Higher Today
    fool.com

  • Cramer Shares His Thoughts On Kodak, Apple And More
    benzinga.com

  • EDGAR Filing Documents for 0001562762-21-000009
    sec.gov

  • Pacific Biosciences Grants Equity Incentive Awards to New Employees
    globenewswire.com

    Pacific Biosciences Grants Equity Incentive Awards to New Employees

    MENLO PARK, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a…

  • SoftBank Takes Stake in DNA Firm Pacific Biosciences
    bloombergquint.com

    SoftBank Takes Stake in DNA Firm Pacific Biosciences

    (Bloomberg) — SoftBank Group Corp. has taken a stake of about 6% in Pacific Biosciences of California Inc., a U.S. DNA-sequencing company whose stock has risen sevenfold in the last year, according to a person with knowledge of the investment.

  • Portfolio Manager Thinks Gene-Editing Stocks Could Outperform Tesla
    gurufocus.com

    Portfolio Manager Thinks Gene-Editing Stocks Could Outperform Tesla

    Portfolio Manager Thinks Gene-Editing Stocks Could Outperform Tesla, Stocks: TSLA,EDIT,CRSP,NTLA,ARKG,PACB,FATE,NVTA,IOVA,EXAS, release date:Jan 08, 2021

  • Wellcome Sanger Institute Increases Investment in PacBio Long-Read Sequencing to Support Darwin Tree of Life Research Initiative
    benzinga.com

    Wellcome Sanger Institute Increases Investment in PacBio Long-Read Sequencing to Support Darwin Tree of Life Research Initiative

    MENLO PARK, Calif ., Jan. 08, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:PACB), a leading provider of high-quality, long-read …

  • The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs
    benzinga.com

    The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs

    Here's a roundup of top developments in the biotech space over the last 24 hours.
    Scaling The Peaks
    (Biotech Stocks Hitting 52-week Highs Jan. 7) …

  • Global Oncology Precision Medicine Market (2020 to 2030) - Analysis and Forecast
    benzinga.com

    Global Oncology Precision Medicine Market (2020 to 2030) – Analysis and Forecast

    Dublin, Jan. 05, 2021 (GLOBE NEWSWIRE) — The “Global Oncology Precision Medicine Market: Focus on Application Area, Ecosystem Type, Country Data (15 …

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen fĂŒr Kommentare, die der Community helfen.

  • Mehr Informationen fĂŒr alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Aktie: PACIFIC BIOSCIEN

Das Unternehmen PACIFIC BIOSCIEN aus USA beschÀftigt 412 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie tÀtig.

Die PACIFIC BIOSCIEN Aktie konnte seit dem 30.04.2012 eine Rendite von bemerkenswerten 275% erwirtschaften.

PACIFIC BIOSCIEN ist nur in 9 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter Global X Genomics & Biotechnology ETF gewichtet PACIFIC BIOSCIEN mit 3,35% im ETF.

Entdecke die 6 ETFs in denen PACIFIC BIOSCIEN am höchsten gewichtet ist Insgesamt in 9 ETFs enthalten

Dir gefallen die Informationen zu PACIFIC BIOSCIEN?

Börsen-Artikel (Arbeitstitel) bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstĂŒtzen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und fĂŒr einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, Österreich oder UK zu kaufen. Wenn du das ĂŒber meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu PACIFIC BIOSCIEN?

Börsen-Artikel (Arbeitstitel) bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstĂŒtzen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das ĂŒber diesen Link machst unterstĂŒtzt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhĂ€lt 20€ und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu PACIFIC BIOSCIEN?

Börsen-Artikel (Arbeitstitel) bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstĂŒtzen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20€ wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu PACIFIC BIOSCIEN?

Börsen-Artikel (Arbeitstitel) bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstĂŒtzen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Aktiendepot bei Trade Republic, mit dem du mit einem pauschalen Euro OrdergebĂŒhren Aktien kaufen kannst. Wenn du das ĂŒber meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15€ von Trade Republic geschenkt:

Zu Trade Republic